Roche's (ROG SW) Pharma Head Graham says we continue to think that the obesity drug market will be over USD 100bln

Roche's Pharma Head indicates a strong outlook for the obesity drug market, projecting it to exceed USD 100 billion.

Newsquawk StaffPublished On the live feed at 6 more headlines followed before this page went public
Newsquawk headlinesUTC

EU Loans to Companies YoY (Dec) Y/Y 3.0% (Prev. 3.1%)

EU Loans to Households YoY (Dec) Y/Y 3% vs. Exp. 2.9% (Prev. 2.9%)

Roche's (ROG SW) Pharma Head Graham says we continue to think that the obesity drug market will be over USD 100bln

Nokia's (NOKIA FH) CEO says that data centre business is still mainly in the US, adding that AI is emerging in EU and Asia

STMicroelectronics (STM FP) December's consumer electronics chip shipment rose by more than 8%; led by mobile and PC components

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This bullish sentiment could suggest Roche's strategic positioning in a growing segment, potentially driving future investment and M&A activity in pharmaceuticals. The implications extend to competitor evaluations and overall market sentiment in related sectors, influencing equities and potentially impacting currency flows linked to Swiss companies.

Related headlines

The whole workspace, free to try.

Try it free